Detailed anatomical tracing and mapping of the viscerotopic organization of the vagal motor nuclei has provided insight into autonomic function in health and disease. To further define specific cellular identities, we paired information based on visceral connectivity with a cell-type specific marker of a subpopulation of neurons in the dorsal motor nucleus of the vagus (DMV) and nucleus ambiguus (nAmb) that express the autism-associated MET receptor tyrosine kinase. As gastrointestinal disturbances are common in children with autism spectrum disorder (ASD), we sought to define the relationship between MET-expressing (MET1) neurons in the DMV and nAmb, and the gastro- 
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A promoter variant that regulates gene expression of MET (the rs1858830 C allele), as well as a truncating mutation in a family pedigree, have been associated with autism spectrum disorder (ASD) (Campbell et al., 2006; Lambert et al., 2014; Sousa et al., 2009; Thanseem et al., 2010) . The rs1858830 C allele is also associated with ASD in children whose mothers express autoantibodies to fetal brain proteins (Heuer, Braunschweig, Ashwood, Van de Water, & Campbell, 2011) . This common variant is significantly enriched in children with both ASD and co-occurring gastrointestinal disturbances (GID) compared to ASD-only or unaffected children ). Overall, children with ASD are more than four times as likely to have a GID compared to non-ASD individuals, most commonly presenting with constipation and abdominal pain (Aldinger, Lane, VeenstraVanderWeele, & Levitt, 2015; Chaidez, Hansen, & Hertz-Picciotto, 2013; Chandler et al., 2013; Gorrindo et al., 2012; Ibrahim, Voigt, Katusic, Weaver, & Barbaresi, 2009; McElhanon, McCracken, Karpen, & Sharp, 2014; Valicenti-McDermott et al., 2006) . In addition, a high prevalence of food selectivity may either be an indication of GID in children with ASD, or contribute to GID in extreme cases (Emond, Emmett, Steer, & Golding, 2010; Levy et al., 2007; Bandini et al., 2010) . There is convergence of MET involvement in both ASD and GID. However, the biological significance of levels of MET expression and receptor signaling in relation to gastrointestinal function, particularly with a co-diagnosis of ASD, may be complex, given that the receptor is expressed in relevant brainstem nuclei, and in peripheral cell populations in the alimentary tract (Avetisyan et al., 2015; Sonnenberg, Meyer, Weidner, & Birchmeier, 1993; Wu & Levitt, 2013) . Deep phenotyping, developmentally and in young adults, may provide opportunities to determine the role of MET in the central regulation of gastrointestinal function.
Vagal motor activity is known to modulate gastrointestinal function through innervation arising from the dorsal motor nucleus of the vagus (DMV) and nucleus ambiguus (nAmb) in the brainstem. Bilateral projections from the DMV and nAmb course peripherally along with sensory projections arising from the nodose ganglia to innervate the heart, airways, liver, kidney, pancreas, and gastrointestinal tract from the esophagus to the ascending colon (Berthoud, Carlson, & Powley, 1991; Bieger & Hopkins, 1987; Fox & Powley, 1985) . Specific subsets of vagal neurons, defined by their projections, coordinate distinct motor programs including modulation of gastrointestinal motility, opening of the lower esophageal sphincter, stimulation of gastric acid release, and pancreatic secretion (Dragstedt, Harper, Tovee, & Woodward, 1947; Rattan & Goyal, 1974; Schwartz, Holst, & Fahrenkrug, 1978) for review see (Furness, Callaghan, Rivera, & Cho, 2014) . The vagal motor nuclei are highly organized forming a viscerotopic map delineated by connectivity to each target tissue (Berthoud et al., 1991; Bieger & Hopkins, 1987; Fox & Powley, 1985) . Understanding of vagal motor neuron function in health and disease has been advanced by relating functional data from selective vagotomy and electrophysiology, with detailed anatomical tracing and mapping of the viscerotopic organization of the DMV and nAmb. Here, we report data probing cell-type specific phenotypes within the vagal motor nuclei that focus on neurons that express the MET receptor. Using a Met EGFP transgenic reporter line, in situ hybridization, immunocytochemistry, and retrograde tracing, we determine the timing of MET expression in the developing brainstem in mouse and nonhuman primate, classify the neurochemical phenotypes of the MET expressing subpopulation, as well as identify target organs innervated. Furthermore, through analyzing Hgf gene expression in both the central nervous system and periphery, we identify putative sites of action of HGF-MET signaling as the vagus nerve establishes connectivity.
| M E TH ODS

| Animals
Animal care and experimental procedures were performed in accord- show that the expression of EGFP recapitulates endogenous Met transcript expression in founder lines (Kast, Wu, Williams, Gaspar, & Levitt, 2017) . Here, brains from mice of the F1 generation carrying the BX139 transgene (determined by PCR) were examined on postnatal day (P) 0 for EGFP and MET immunoreactivity (see below). Line 17 and line 18 exhibited the greatest fluorescence intensity for EGFP, and expression patterns of EGFP that coincided with the pattern of MET at this age.
All analyses were carried out using subsequent generations of line 18, designated as Met
EGFP
. This line has a copy number of 6 EGFP transgene insertions based on a Taqman GFP Copy Number Assay (Thermo
| Immunostaining
Tissue for immunofluorescence staining was collected from mice on embryonic day (E) 11.5, 13.5, and 16.5, and P0, 7, 14, 25, 45, and 60. Tissue samples from both male and female mice were collected on P25 Here, sections were stored at 2808C until used for MET and ChAT immunohistochemical processing, as previously described (Judson, Bergman, Campbell, Eagleson, & Levitt, 2009 
| Wholemount Immunostaining and Tissue Clearing
Wholemount analysis of antigen localization was performed in mouse embryos processed for tissue clearing using the iDISCO protocol (Renier et al., 2014 in PBS/0.2% TritonX-100/20% DMSO/0.3M glycine at 378C overnight. Samples were blocked in PBS/0.2% TritonX-100/10% DMSO/ 6% normal donkey serum at 378C for 1-3 days, depending upon the age of the sample (Renier et al., 2014) . 
| Antibody Characterization
Antibodies used in this study are summarized in Table 1 , and described in greater detail by corresponding number below.
1. The polyclonal rabbit anti-CART antibody (RRID:AB_2313614) recognizes mouse, rat, bovine, and human CART peptide 55-102, with some cross-reactivity to human CART peptide 61-102, as indicated by the manufacturer. Specificity of this antibody has been demonstrated by preabsorption with 10 mg/mL CART peptide 55-102, which is sufficient to abolish staining in rat pelvic ganglia (Dun, Dun, Wong, Yang, & Chang, 2000) . Patterns of immunoreactivity in histological staining with RRID:AB_2313614 are consistent with those Ile -Pro -Ile -Tyr -Glu -Lys -LysTyr -Gly -Gln -Val -Pro -Met -CysAsp -Ala -Gly -Glu -Gln -Cys -AlaVal -Arg -Lys -Gly -Ala -Arg -IleGly -Lys -Leu -Cys -Asp -Cys -ProArg -Gly -Thr -Ser -Cys -Asn -SerPhe -Leu -Leu -Lys -Cys -Leu using other CART antibodies (Dun, Castellino, Yang, Chang, & Dun, 2001; Parker, Kumar, Lonergan, & Goodchild, 2013) , as well as our own staining for CART in the brainstem of developing and adult mice.
2. Antibodies directed against ChAT used in this study have been widely used in a variety of species including mouse (Corsi & Coyle, 1991; Gautron et al., 2013) , rat (Bhagwandin, Fuxe, & Manger, 2006) , cat (Shiromani et al., 1987) , zebrafish (Clemente et al., 2004) , monkey ( Chang & Kuo, 1991; Puller, Manookin, Neitz, Rieke, & Neitz, 2015) , and human (German, Bruce, & Hersh, 1985) . The original investigators generating this antibody demonstrate specificity, as only a single band around 68-70 kDa was recognized following SDS-PAGE of the ammonium sulfate fraction of placental tissue sample (Bruce, Wainer, & Hersh, 1985) . In addition, immunohistochemical staining using ChAT antibody in our study is consistent with previously reported anatomical patterns of acetylcholinesterase expression in both mouse and monkey (Gautron et al., 2013; Jacobowitz & Abbott, 1997; Paxinos, 2009 ).
3. Two chicken anti-GFP antibodies were used in this study, the first of which recognizes a single band around 25 kDa in western blots from HEK293 cells transfected with GFP according to the manufacturer. Furthermore, no staining is observed in tissue from wild-type cell lysates.
4. The second chicken anti-GFP antibody used in this study was used specifically for iDISCO tissue processing, as it is compatible with methanol treatment (Renier et al., 2014) . The manufacturer reports that samples from transgenic animals expressing GFP analyzed by western blot exhibit a single 25 kDa band. Both GFP antibodies used in this study displayed identical patterns of immunoreactivity in brainstem sections from METEGFP reporter mice.
5. Two separate anti-MET antibodies were used in this study to identify MET in samples from the mouse and non-human primate.
Mouse monoclonal anti-MET antibody, RRID:AB_331361, was used to identify MET protein in rhesus macaque brainstem sections. AB_355414, was used to localize MET protein in mouse brainstem.
Specificity of this antibody has been demonstrated in western blots
from wild-type mice recognizing a single band at approximately 145 kDa, whereas no band is detected in cortical tissue samples from conditional null mice in which MET was deleted from the dorsal pallium (Eagleson, Milner, Xie, & Levitt, 2013) . Immunofluorescence staining with RRID:AB_355414 is consistent with in situ hybridization data (Wu & Levitt, 2013) , as well as patterns of immunoreactivity observed using the mouse monoclonal MET antibody described above.
7. Monoclonal anti-neurofilament antibodies used in this study were originally developed using E14-E15 rat spinal cord as the immunogen (Dodd, Morton, Karagogeos, Yamamoto, & Jessell, 1988 (Myers, Lazzarini, Lee, Schlaepfer, & Nelson, 1987) . Immunofluorescence staining in mouse tissue in the current study is consistent with the pattern of immunoreactivity described in previous studies (Cordes, 2001 ).
8. The polyclonal rabbit anti-TH antibody (RRID:AB_390204) recognizes human, rat, and mouse TH peptide according to the manufacturer. Extensive characterization of this antibody has been performed demonstrating that it recognizes a single band of approximately 62 kDa in both mouse and zebrafish neural tissue samples (Yamamoto, Ruuskanen, Wullimann, & Vernier, 2010) . Furthermore, patterns of immunoreactivity for this antibody in brain tissue are similar across several mammalian species including rats, mice, hamsters, and prairie voles (Northcutt, Wang, & Lonstein, 2006 ).
| In Situ Hybridization
Fetal mice, on E13.5 and E15.5, were prepared for in situ hybridation (Eagleson et al., 2016a; Wu & Levitt, 2013) . The uterine horns were removed and fetuses were dissected in ice cold PBS, fixed in 4% paraformaldehyde in PBS (pH 7.4) overnight at 48C, and cryoprotected in AK042121). ISH was performed as described previously (Wu & Levitt, 2013; Wu et al., 2009 Tween-20 in distilled water) with gentle agitation at room temperature.
Slides were then blocked for 1 hr at room temperature with blocking reagent (100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1.5% Blocking Reagent (Roche, Indianapolis, Ind.)), and incubated at 48C overnight in solution with alkaline phosphatase-conjugated anti-DIG Fab fragments sutures. Ketoprofen (5 mg/kg) was administered subcutaneously to limit inflammation, and bupivacaine (1mg/kg) was applied subcutaneously just prior to closure along the wound margin to provide analgesia.
The overlying skin was closed with 5-0 PROLENE® suture, and the incision site was gently cleaned with chlorohexidine solution. After 3-day survival period, mice were perfused transcardially with 4% paraformaldehyde buffered fixative and tissue was processed for immunohistochemistry, as described above.
| Imaging and Analysis
Immunofluorescence images were acquired using a Zeiss LSM 710 laser scanning confocal microscope equipped with 103, 203, and 633
oil-corrected objectives. Confocal image stacks used for identification of vagal trajectories in wholemount iDISCO-processed tissue samples stained for EGFP and neurofilament were collected through the z-axis at a frequency of 7.36 lm using a 103 objective. Imaris image analysis software (Bitplane, RRID:SCR_007370) was used to extract a contour map that served as a three-dimensional object rendering of the vagus nerve. This was accomplished by manually drawing an outline encompassing the contours of the nerve. The vagus was identified anatomically using localization of neurofilament immunoreactivity, and outlines were drawn on consecutive two-dimensional optical image slices throughout the entire image stack using the 'contour surface' tool. The extracted contour surface map containing the vagus nerve was used to generate a mask, such that all neurofilament staining except for the vagus was subtracted. In this ROI, which only contained the vagus nerve, colocalization of EGFP with neurofilament was assayed along the length of the nerve and its branches.
For cell counts of EGFP and CTB labeled neurons, every fourth consecutive section (20 lm) was imaged through its entire thickness.
Confocal image stacks were collected through the z-axis at a frequency of 1.14 lm using a 203 objective. The 'cell counter' plugin in ImageJ software (version 1.46r, SCR_003070) facilitated manual counting of EGFP and CTB labeled neurons in confocal image stacks, for which the estimated number of cells per section was calculated in accordance with Abercrombie's formula (Abercrombie, 1946) .
Images of sections processed for in situ hybridization were captured using a Zeiss Axio Observer inverted confocal microscope equipped with 23 and 53 objectives and a color CCD camera. Immunohistochemistry in rhesus macaque brainstem sections was visualized and imaged using a Leica DMI6000B inverted microscope equipped with a 103 objective and a color CCD camera.
All images are globally adjusted for brightness and contrast, and converted to TIFF format for publication using Adobe Photoshop CS5.
| Statistical Analysis
Data are graphed using GraphPad Prism software (RRID: Overall, the majority of neurons within the nAmb were EGFP1, but the extent of labeling varied among subregions (Figure 3g, h ). In the more rostrally located compact formation, nearly all of the neurons were EGFP1. In contrast, within the semicompact formation, very few EGFP1 neurons were observed on P0. The extent of EGFP1 labeling in the semicompact formation increased during postnatal development and remained evident at P60. There also were EGFP1 neurons in the loose and external formations of the nucleus ambiguus, which supply the laryngeal nerves, and heart, respectively.
In addition to the vagal motor nuclei, EGFP1 neurons were located in the caudal portion of the dorsal raphe nucleus, as reported by Kast et al. (2017) , the spinal trigeminal nucleus, and neurons situated in the nucleus of the solitary tract. There also were a few, scattered EGFP1 neurons located at the lateral borders of the hypoglossal nucleus of the 12th cranial nerve (n12), that were most apparent at perinatal ages (Figure 3c ).
To determine whether these general brainstem patterns of MET expression are conserved in the developing primate, we processed for MET immunocytochemistry a series of fixed brainstem sections from third trimester rhesus monkeys at two different prenatal ages. There were similar patterns of MET protein expression to those observed in the mouse. On GD123 and GD151, MET was observed in a subpopulation of cells along the ventrolateral border of the DMV (Figure 4g, h ). There was clear MET labeling of neuronal somata in the nAmb on GD123, but by GD151, immunostaining was reduced in intensity with more apparent neuropil labeling (Figure 4a, b) . In addition to the DMV and nAmb, MET immunostained neurons and neuropil were evident in the nucleus of the solitary tract, the spinal trigeminal nucleus, and the caudal portion of the dorsal raphe (Figure 4d , e), consistent with patterns of MET expression described in the mouse (Kast et al., 2017; Wu & Levitt, 2013) .
| Neurotransmitter and neuropeptide phenotypes of vagal MET neurons
To determine the neurotransmitter and neuropeptide phenotype of MET neurons in the DMV and nAmb on P0 and P60, we used antibodies against Choline Acetyltransferase (ChAT), cocaine-and amphetamine-regulated transcript (CART), and tyrosine hydroxylase (TH), all of which are expressed by discrete populations of brainstem vagal neurons. All EGFP1 neurons in the DMV and nAmb coexpressed ChAT, however, not all ChAT expressing neurons were EGFP1 (Figure 5a , b, g, h). Of EGFP1 neurons in the lateral column of the DMV, 26.5% (64.8, n 5 6) were also found to co-express CART at either P0 or P60 (Figure 5c, d) . CART-immunoreactive puncta were evident in the neuropil of nAmb, but none of these profiles were EGFP1 (Figure 4i, j) . TH was not co-expressed by EGFP1 neurons in either the DMV or nAmb at either age (Figure 5e , f, k, l).
| Hgf is expressed by a subset of vagal brainstem targets
expressed concurrently in the fetal brainstem (Wu & Levitt, 2013) (Figure 6g , g1, h, and h1).
| MET expressing neurons exhibit complex peripheral projections
To more fully understand the potential relationship between MET expression patterns and putative functional subgroups of vagal motor neurons, multiple methods were used. Experiments were designed using the Met EGFP mouse line to determine the trajectories and innervation targets of vagal motor neurons that express EGFP. First, wholemount iDISCO immunostaining and tissue clearing was carried out in E11.5 and E13.5 embryos (Figure 7a-f ). This allowed direct visualization of EGFP1 cell bodies in the brainstem, as well as providing an ability to map their axonal projections to specific peripheral targets.
This strategy provides the ability to disambiguate vagal brainstem patterns of innervation from those that potentially could arise from sympathetic postganglionic neurons or enteric neurons, which express MET (Avetisyan et al., 2015; Maina et al., 1998) .
Neurofilament staining was used as a marker to facilitate analysis of EGFP1 signal within peripheral axons. The subset of neurofilament labeling that corresponds to the vagus nerve was identified, along which the presence of EGFP1 labeling was assessed, using Imaris software (Figure 7b, c) . Within the vagus nerve, EGFP1 axonal projections coursed along the length of the main vagal trunks (Figure 7e) . A welldefined branch of the main trunk of the vagus contained EGFP1 axons that ascended rostrally, corresponding anatomically to the laryngeal nerves (Figure 7d ), which supply innervation to the airways and pharyngeal constrictors. EGFP1 axons also were observed entering the gastric vagal branches along the stomach (Figure 7f ).
The iDISCO methodology facilitated visualization of EGFP1 vagal trajectories. To further examine minor vagal branches and individual axonal fibers, whole body sagittal sections were cut and examined on E13.5, E16.5, and P0 for MET EGFP labeling, again using neurofilament staining to identify axonal projections. Consistent with results from iDISCO staining and tissue clearing, EGFP1 axons were evident in the laryngeal branches of the vagus, as well as in finer branches extending to the muscles surrounding the larynx (Figure 7g ). Fine EGFP1 axons also were observed along the length of the external muscular layer of the esophagus (Figure 6h ). In addition, a dense front of accumulated EGFP1 axons was observed enveloping the stomach (Figure 7i ). 
| D I SCUSSION
Gastrointestinal disturbances (GIDs) are common in children with ASD, potentially reflecting a shared biological vulnerability that could impact both neurological and gastrointestinal functions. In fact, there is shared genetic burden for psychiatric and co-occurring medical conditions that indicates convergent biological risk may be common between brain and periphery (Plummer, Gordon, & Levitt, 2016) . Consistent with this hypothesis, we reported previously an enrichment of a promoter variant in the MET gene in families of children with ASD and cooccurring GID, compared to children diagnosed with ASD only ). The promoter variant reduces MET expression by 30-50%, measured in human immune cells (Heuer et al., 2011) and neocortex (Campbell et al., 2007; Voineagu et al., 2011) . The underlying biological processes connecting ASD and GID are unknown, but could include central and peripheral involvement of shared risk factors, such as pleiotropic genes like MET, or factors related to the gut microbiome (Sharon, Sampson, Geschwind, & Mazmanian, 2016 ).
In the current study, we took advantage of a Met EGFP transgenic mouse line, which we show here in the vagal brainstem, and in other studies (Kast et al., 2017) , exhibits high fidelity expression of an EGFP reporter to label MET expressing neurons. In the following discussion, formations (Altschuler, Bao, & Miselis, 1991; Bieger & Hopkins, 1987) .
The compact, semicompact, and loose formation are comprised of special visceral efferent neurons, while the ventrally located external formation is comprised of general visceral efferent neurons (Bieger & Hopkins, 1987) . The majority of MET1 neurons of the nAmb were positioned within the compact formation, a region containing neurons that project directly to motor endplates located in the striated muscle of the esophagus, as well as supplying the superior laryngeal branch of the vagus nerve (Bieger & Hopkins, 1987; Neuhuber, Kressel, Stark, & Berthoud, 1998; Pascual-Font et al., 2011) . iDISCO analysis and immunostaining in sections further confirmed innervation of the esophagus by EGFP1 axons. These vagal connections facilitate peristalsis and propulsion of ingested food down the length of the esophagus (Crist, Gidda, & Goyal, 1984; Mukhopadhyay, & Weisbrodt, 1975; Kravitz, Snape, & Cohen, 1978; Powley et al., 2013) .
In addition to innervation of the esophagus, MET1 neurons project to the muscles surrounding the larynx. Special visceral efferent innervation of the laryngeal muscles arises from both the superior and recurrent laryngeal branches of the vagus (Bieger & Hopkins, 1987; Pascual-Font et al., 2011) . Neurons projecting within the superior laryngeal branch are located within the compact formation of the nAmb (Bieger & Hopkins, 1987) . By contrast, neurons projecting within the recurrent laryngeal branch are located within the loose formation of the nAmb (Bieger & Hopkins, 1987) . (Schemann & Grundy, 1992) . This population of MET1 neurons in the medial DMV was largely localized rostral to the obex. Functional differences between gastric-projecting neurons located rostrally versus caudally within the DMV have been described in rodents using the excitatory neurotransmitter, glutamate (L-glu), to stimulate anatomically distinct subsets of DMV neurons. Microinjection of L-glu in the rostral portions of the DMV facilitates increases in intragastric pressure and gastric contraction, while L-glu microinjection to the caudal DMV reduces intragastric pressure and mediates gastric relaxation (Krowicki et al., 2002; Monroe, Hornby, & Partosoedarso, 2004; Zhou, Lu, Yao, & Owyang, 2008) . In addition, the rostral DMV receives dense thyrotropin-releasing hormone innervation from the caudal raphe nuclei that stimulates descending gastric contraction and gastric acid secretion (Hornby et al., 1989; Yang, Ohning, & Tach e, 1993) . Therefore, the position of the rostrally located MET1 neurons that project to the stomach is consistent with a role in modulating gastric contraction, gastric emptying, or gastric acid secretion.
The lateral column of the DMV contains a distinct subpopulation of MET1 neurons, which project to either the cecum or proximal colon. Interestingly, in a pilot study, double injections using CTB conjugated to spectrally distinct fluorophores, consistently revealed a small overlap of approximately 15% of neurons projecting to both the cecum and proximal colon. This suggests that the MET1 neurons projecting to the cecum or proximal colon are mostly distinct subgroups, but do contain a proportion that overlap and may perform dual roles. Functionally, vagal neurons projecting to the cecum stimulate cecal contraction (Berthoud et al., 1991; Lee & Nakayama, 1981) . Vagal stimulation also increases ileocecal sphincter pressure, which provides a barrier against reflux of bacteria-rich colonic contents into the small intestine (Phillips, Quigley, Kumar, & Kamath, 1988; Rubin, Cardwell, Ouyang, Snape, & Cohen, 1981) . In addition, vagal neurons projecting to the proximal colon are thought to modulate increased contraction and motility in both rodents and primates (Dapoigny, Cowles, Zhu, & Condon, 1992; Tong, Ridolfi, Kosinski, Ludwig, & Takahashi, 2010) . Thus, the laterally positioned population of MET1 neurons, together with medially located MET1 neurons in the DMV, and MET1 neurons of the nAmb, are each positioned to modulate control of distinct regions of the gastrointestinal tract. Future studies will be required to determine precisely how each population of MET1 neurons impacts gastrointestinal function.
| Implications of developmental expression of ligand and receptor
HGF is absent from the embryonic brainstem as MET1 vagal neurons migrate and extend axonal projections to the viscera (Wu & Levitt, 2013) . Thus, it is likely that the expression patterns of HGF peripherally during development reflect putative sites of MET receptor activation on developing vagal axons from MET1 subpopulations of neurons.
Outside of the nervous system, HGF was described originally for its role in liver cell proliferation and in epithelial cell motility (Nakamura et al., 1989; Stoker et al., 1987) . HGF also acts as an epithelial cell morphogen in the kidney, lung, colon, and mammary glands (Brinkmann, Foroutan, Sachs, Weidner, & Birchmeier, 1995; Yang, Spitzer, Meyer, & Sachs, 1995) , as well as in tumor formation and metastasis (Birchmeier, Birchmeier, Gherardi, & Vande Woude, 2003; Park et al., 1986; Rong et al., 1992) . HGF also is critical for muscle formation in the developing tongue and limb buds (Bladt, Riethmacher, Isenmann, Aguzzi, & Birchmeier, 1995; Scaal et al., 1999) . Therefore, it is important to emphasize that not all sites of peripheral HGF expression are relevant to vagal brainstem MET1 neuron signaling, the focus of the current study. HGF is expressed in several developing sites to which MET1 vagal motor neurons project, as vagal efferents begin to contact the gastrointestinal tract (Rinaman & Levitt, 1993) . In situ hybridization experiments demonstrate that HGF is expressed in cells located in the airways, esophagus, and at scattered points along the intestines. Each of these sites is a target of MET1 vagal motor neurons, identified by either retrograde neuronal tracing experiments in adults, or analysis of wholemount iDISCO immunostaining embryonically. One potential inconsistency was the lack of HGF expression in the stomach of E13.5 or E15.5 mouse embryos. Studies in rat demonstrated a peak in HGF expression in fetal rat stomach around E19 (Matsubara et al., 1998) . In addition, the mature enteric nervous system co-expresses both MET and HGF in a subset of neurons (Avetisyan et al., 2015) . Therefore, the fetal ages that we examined in mice may have been too early to observe HGF expression in the stomach or enteric nervous system.
The mechanisms governing the growth and guidance of vagal motor efferents to the gastrointestinal tract, as well as the significance of HGF for these developmental processes are under investigation.
HGF produced by the branchial arches serves as a potent chemoattractive and survival factor for cranial branchiomotor neurons (Caton et al., 2000) . This could also apply to developing MET1 vagal motor neurons.
However, studies performed in hgf null embryos demonstrate that while the hypoglossal nerve exhibits severe defects, the vagus nerve appears relatively intact at a gross level (Caton et al., 2000) . The vagus is a mixed nerve, however, composed of approximately 80% sensory axon fibers (Foley & DuBois, 1937) . Therefore, alterations in a small subset of vagal axons that are MET1, would likely go undetected without specific application of genetic tools for molecular labeling. These studies are underway in our laboratory.
| Biological points of convergence for ASD and GID
As a point of convergence with co-morbidity for ASD and GID risk, we find here that the organization of developing and mature MET1 vagal 
